An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes.
Saved in:
| Other title: | FDA Reauthorization Act of 2017 |
|---|---|
| Format: | Government Document Book |
| Language: | English |
| Published: |
[Washington, D.C.] :
[U.S. Government Publishing Office],
2017.
|
| Subjects: |